aTyr Pharma | LIFE - Ativos





Ativos Alterar Data
Alterity Therapeutics Limited AUD 37.98M 15.78M 2025-12
Ardelyx USD 504.51M 2.9M 2026-03
aTyr Pharma USD 69.82M 9.83M 2026-06
Biogen USD 32.09B 2.6B 2026-06
Bristol-Myers Squibb USD 87.63B 1.16B 2026-06
Cipla INR 424.96B 23.32B 2026-03
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 145.86M 10.71M 2026-03
CSL USD 37.9B 1.5B 2025-12
Curis USD 29.69M 9.72M 2026-03
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
Grifols EUR 23.15B 142.7M 2025-12
Lakefront Biotherapeutics EUR 3.35B 21.24M 2026-06
Novartis USD 122.03B 3.5B 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
United Therapeutics USD 7.22B 505.9M 2026-06